Loading organizations...
BA Capital is an investment firm cultivating a specialized portfolio of high-growth companies within China's innovative consumption sector. Leveraging deep industry expertise and extensive networks, it identifies and supports promising ventures. The firm strategically deploys capital into businesses redefining consumer experiences and product offerings across China's dynamic market.
Established in February 2016, BA Capital was co-founded by David He Yu, Michael Zhang, and Feng Chen. He Yu, previously leading strategic investment at ByteDance and serving at Orchid Asia, partnered with Zhang, an Orchid Asia alumnus. Their insight recognized rapidly evolving opportunities in China’s consumer market, prompting a venture capital firm for innovative consumption.
BA Capital partners with consumer-related companies throughout China, providing capital and strategic guidance for accelerated development. Its long-term vision focuses on fostering a robust ecosystem of innovative consumer brands and services. The firm aims to drive consumption's future through targeted investments and collaborative growth.
BA Capital has 2 tracked investments across 2 companies. The latest tracked deal is $70.2M Series B in Laoken Medical Technology in January 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2024 | Laoken Medical Technology | $70.2M Series B | BA Capital, Genbridge Capital | Challenjers Venture, CMC Capital, Gaorong Capital |
| Feb 11, 2022 | Harmay | $200.0M Series C | General Atlantic | Cygnus Equity, Eastern Bell Capital, Five Arrows, Hillhouse Venture, N5 Capital, Ocean Link |
